Holocene Advisors »

Revance Therapeutics shares owned by Holocene Advisors

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Holocene Advisors from 13F filings

Historical chart of Holocene Advisors investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Holocene Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Holocene Advisors

Quarter filed Position value Share count Share price at filing
2023-06-30 $21M 843k 25.31
2023-03-31 $30M 936k 32.21
2022-12-31 $24M 1.3M 18.46
2022-09-30 $29M 1.1M 27.00